Rwanda begins Marburg vaccinations to curb deadly outbreak

The country has already received shipments of the vaccines, including from the Sabin Vaccine Institute.
Rwanda said on Sunday it had begun administering vaccine doses against the Marburg virus to try to combat an outbreak of the Ebola-like disease in the East African country, where it has so far killed 12 people.
"The vaccination is starting today immediately," Health Minister Sabin Nsanzimana said at a news conference in the capital, Kigali.
More To Read
- Rwanda marks Liberation Day, praises Kenya for decades of support
- Rwandan President Kagame reignites controversy over Tshisekedi’s rise to power
- Amnesty International slams DRC-Rwanda peace deal for ignoring war crimes accountability
- IOM welcomes Rwanda–DRC peace deal, urges tangible impact for displaced communities
- Rwanda to host 2025 World Kiswahili Language Day celebrations in Kigali
- DRC-Rwanda peace deal: What you need to know
He said the vaccinations would focus on those "most at risk, most exposed healthcare workers working in treatment centres, in hospitals, in ICUs, in emergencies, but also the close contacts of the confirmed cases."
The country has already received shipments of the vaccines, including from the Sabin Vaccine Institute.
Rwanda's first outbreak of the viral hemorrhagic fever was detected in late September, with 46 cases and 12 deaths reported since then. Marburg has a fatality rate as high as 88%.
Marburg symptoms include high fever, severe headaches and malaise within seven days of infection, and later severe nausea, vomiting, and diarrhoea.
It is transmitted to humans by fruit bats and then spreads through contact with the bodily fluids of those infected. Neighbouring Uganda has suffered several outbreaks in the past.
"We believe that with vaccines, we have a powerful tool to stop the spread of this virus," the minister said.

Other Topics To Read
Top Stories Today